Uneingeschränkter Zugang

Oxidative and apoptotic effects of fluoxetine and its metabolite norfluoxetine in Daphnia magna


Zitieren

Figure 1

Chronic effects of fluoxetine, norfluoxetine, and their combinations at environmental or 10-fold environmental concentrations on mitochondrial membrane potential in Daphnia magna (200 μm)
Chronic effects of fluoxetine, norfluoxetine, and their combinations at environmental or 10-fold environmental concentrations on mitochondrial membrane potential in Daphnia magna (200 μm)

Figure 2

Effects of fluoxetine, norfluoxetine, and their combinations at subacute, 100-fold environmental concentrations on mitochondrial membrane potential in Daphnia magna (200 μm)
Effects of fluoxetine, norfluoxetine, and their combinations at subacute, 100-fold environmental concentrations on mitochondrial membrane potential in Daphnia magna (200 μm)

Figure 3

Chronic effects of fluoxetine, norfluoxetine, and their combinations at environmental or 10-fold environmental concentrations on cytochrome c and ERK 1/2 protein levels in Daphnia magna. A – control; B– fluoxetine; C– norfluoxetine; D– fluoxetine+norfluoxetine; E – 10 x fluoxetine; F – 10 x norfluoxetine; G– 10 x fluoxetine+10 x norfluoxetine
Chronic effects of fluoxetine, norfluoxetine, and their combinations at environmental or 10-fold environmental concentrations on cytochrome c and ERK 1/2 protein levels in Daphnia magna. A – control; B– fluoxetine; C– norfluoxetine; D– fluoxetine+norfluoxetine; E – 10 x fluoxetine; F – 10 x norfluoxetine; G– 10 x fluoxetine+10 x norfluoxetine

Figure 4

Subacute effects of fluoxetine, norfluoxetine, and their combinations at 100-fold environmental concentrations on cytochrome c and ERK1/2 protein levels in Daphnia magna. A – control; B – 100 x fluoxetine; C – 100 x norfluoxetine; D – 100 x fluoxetine+100 x norfluoxetine
Subacute effects of fluoxetine, norfluoxetine, and their combinations at 100-fold environmental concentrations on cytochrome c and ERK1/2 protein levels in Daphnia magna. A – control; B – 100 x fluoxetine; C – 100 x norfluoxetine; D – 100 x fluoxetine+100 x norfluoxetine

Effects of fluoxetine (Flx), norfluoxetine (NorFlx), and their combinations on GPx, ChE, TBARS, and total protein levels in Daphnia magna

GPx (μmol/min/mg protein) ChE (μmol/min/mg protein) TBARS (nmol/mg protein) Total proteins (mg/mL)
Chronic
Control 0.047±0.010a 0.010±0.003ab 8.169±2.892a 1.143±0.271a
Flx 0.048±0.002a 0.012±0.001bc 8.413±0.999a 0.972±0.038a
NorFlx 0.051±0.004a 0.014±0.001c 11.670±1.347ab 0.996±0.032a
Flx+NorFlx 0.056±0.010ac 0.012±0.002bc 8.750±1.106a 0.948±0.037a
10 x Flx 0.086±0.003b 0.014±0.001c 16.354±3.315b 0.909±0.028a
10 x NorFlx 0.062±0.010c 0.010±0.001ab 21.840±6.003c 0.966±0.125a
10 x Flx+10 x NorFlx 0.050±0.005a 0.007±0.002a 15.600±3.283b 1.029±0.098a
Subacute*
Control 0.063±0.005a 0.016±0.003a 10.635±3.731a 0.681±0.107a
100 x Flx 0.175±0.071bc 0.058±0.020b 67.963±32.735b 0.365±0.048b
100 x NorFlx 0.273±0.221b 0.053±0.009b 24.030±7.179c 0.278±0.071b
100 x Flx+100 x NorFlx 0.129±0.042c 0.054±0.012b 35.388±15.764bc 0.297±0.069b

Chronic effects of fluoxetine, norfluoxetine, and their combinations at environmental or 10-fold environmental concentrations on brood production of D. magna

1st generation offspring 2nd generation offspring 3rd generation offspring 4th generation offspring 5th generation offspring Average
Control 76.8±13.6a 50.1±16.5ac 44.1±16.4a 73.9±15.3a 84.8±32.3ac 65.9±25.1a
Flx 79.8±24.4ac 46.2±5.7a 62.7±18.1b 78.7±32.1a 81.3±29.7a 69.7±26.9a
NorFlx 143.3±44.7b 69.5±25.4cdf 140.7±51.8c 135.6±64.2bc 62.2±22.8cd 110.3±56.6b
Flx+NorFlx 126.3±29.9b 94.3±43.4bd 144.3±29.5c 135.3±68.1b 45.4±9.3b 109.1±53.7b
10 x Flx 129.5±59.0bd 53.5±29.2aeg 60.6±9.3b 84.9±58.6ac 41.8±17.4bd 74.1±48.0ac
10 x NorFlx 70.6±21.9a 42.3±26.8e 57.7±29.9ab 52.7±33.2a 67.6±27.6c 58.2±29.1c
10 10 x x Flx NorFlx + 98.6±31.8cd 64.4±20.0fg 56.8±8.9b 60.6±48.5a 42.3±15.5b 64.5±33.4ac

Confirmation of water concentrations of fluoxetine (Flx) and norfluoxetine (NorFlx) after serial dilution

Concentrations 0.091 μg/L 0.91 μg/L 9.10 μg/L 0.011 μg/L 0.11 μg/L 1.10 μg/L
Flx 0.090±0.007 1.18±0.06 9.39±0.05 - - -
NorFlx - - - 0.010±0.000 0.15±0.01 1.14±0.01

Chronic effects of fluoxetine (Fix), norfluoxetine (NorFlx), and their combinations at environmental or 10-fold environmental concentrations on carapace length, maximum carapace width, and caudal spine length in less than 24 h-old D. magna offspring bom in experimental beakers

Carapace length (pm) Max. carapace width (pm) Caudal spine length (pm) Carapace length (pm) Max. carapace width (pm) Caudal spine length (pm) Carapace length (pm) Max. carapace width (pm) Caudal spine length (pm)
1st generation offspring 2nd generation offspring 3rd generation offspring
Control 777.6±50.4 430.0±41.0 403.2±30.4 880.9±85.9a 473.7±86.9acd 415.3±31.5 847.0±46.1a 490.6±52.8ad 411.5±42.8a
Flx 773.0±37.3 414.5±43.1 385.2±26.4 827.8±76.1b 437.5±62.9c 400.6±33.1 806.9±45.7b 475.6±53.6ac 371.2±42.0b
NorFlx 748.5±30.4 408.5±38.9 354.0±34.6 842.3±72.5b 448.5±66.1ac 403.5±28.6 838.7±41.8a 475.0±38.9ac 378.1±44.4bc
Flx+NorFlx 774.2±33.9 420.9±47.8 367.0±29.3 857.3±56.1a 466.0±55.1ad 397.4±32.3 812.4±45.2b 469.2±45.4bc 369.7±39.9b
10 x Flx 742.6±32.7 400.9±45.8 345.1±25.9 874.1±107.5ab 496.4±97.7de 406.1±43.0 906.2±80.9c 524.4±70.2e 397.3±40.2ac
10 x NorFlx 764.2±34.6 407.6±36.9 358.8±26.2 893.8±101.5ac 521.6±78.7be 401.4±41.7 857.9±69.4a 492.8±68.0abf 379.9±41.5bc
10 x Flx+10 x NorFlx 733.7±34.1 388.5±43.2 349.4±41.9 925.6±102.1c 544.5±81.9b 408.0±53.6 915.7±105.3c 524.0±90.6def 380.3±56.7bc
4th generation offspring 5th generation offspring Average
Control 887.6±22.5a 483.0±31.2a 392.0±31.3ae 899.7±64.5a 497.7±49.2a 385.8±30.3ac 865.0±70.3a 478.3±59.6a 401.0±35.4a
Flx 842.9±27.4bd 456.7±33.7bc 414.1±32.4b 783.7±58.2b 446.4±35.1b 363.0±51.7a 805.9±58.5b 444.5±50.0b 386.8±42.6b
NorFlx 852.2±55.1bc 449.7±52.4b 372.0±28.7cd 890.9±100.1c 503.9±71.5af 389.8±49.7cb 831.1±78.7c 455.8±62.4bd 378.8±41.5c
Flx+NorFlx 878.8±56.8a 473.4±60.4ac 367.7±31.6d 891.2±94.0ac 532.3±63.7c 395.5±35.5cb 836.7±74.8c 468.3±65.8cef 378.7±36.0c
10 x Flx 845.3±47.1bd 454.4±37.5b 395.9±29.0a 836.9±35.9d 462.1±30.5ed 394.0±25.7b 841.0±86.0c 467.6±73.6deg 387.9±39.6bd
10 x NorFlx 855.9±22.2c 480.4±24.8a 394.0±41.5a 838.4±98.5e 476.5±69.7def 386.7±44.6ab 837.8±84.4c 472.2±71.4afg 382.3±41.5cd
10 x Flx+10 x NorFlx 833.0±42.3d 465.9±25.9c 381.0±23.8ce 833.0±88.7de 470.2±61.0be 381.0±45.3ab 849.9±105.7c 480.2±84.1afg 381.0±48.9cd
eISSN:
1848-6312
Sprachen:
Englisch, Slovenian
Zeitrahmen der Veröffentlichung:
4 Hefte pro Jahr
Fachgebiete der Zeitschrift:
Medizin, Vorklinische Medizin, Grundlagenmedizin, andere